Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019

• Anna Maisa,
• Christian Kollan,
• Matthias an der Heiden,
• Florian van Bömmel,
• Markus Cornberg,
• Stefan Mauss,
• Heiner Wedemeyer,
• Daniel Schmidt,
• Daniel Schmidt,
• Sandra Dudareva

Affiliations

Anna Maisa

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

Christian Kollan

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

Matthias an der Heiden

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

Florian van Bömmel

Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany

Markus Cornberg

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

Stefan Mauss

Center for HIV and Hepatogastroenterology, Düsseldorf, Germany

Heiner Wedemeyer

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

Daniel Schmidt

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

Daniel Schmidt

Charité Universitätsmedizin Berlin, Berlin, Germany

Sandra Dudareva

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany